Dedicare (DEDI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
28 Apr, 2026Executive summary
Net sales grew 3.4% year-over-year to SEK 363.3 million, with organic growth at -1.5%.
Adjusted EBITA was SEK 10.7 million, up from SEK 10.4 million, with an adjusted margin of 2.9%.
Underlying profitability improved, especially in Sweden and Denmark, despite currency headwinds in Norway.
The acquisition of WeCare in Denmark contributed positively to both sales and earnings.
Profit for the period increased to SEK 7.9 million from SEK 6.9 million year-over-year.
Financial highlights
EBITA was SEK 9.3 million (down from SEK 10.4 million), with a margin of 2.6% (3.0%).
EBIT was SEK 7.2 million (8.0), and profit after financial items was SEK 10.2 million (8.6).
Basic and diluted EPS were SEK 0.82 (0.72).
Cash flow from operating activities was SEK -7.8 million (39.4), mainly due to working capital changes.
Equity per share rose to SEK 32.08 (30.92).
Outlook and guidance
Signs of market stabilisation, with continued challenging conditions in Norway and the UK.
The company is well prepared for coming quarters, leveraging diversification and rationalisation.
Focus remains on operational efficiency, internationalisation, and exploiting new opportunities.
Latest events from Dedicare
- Sales fell 15.4% in 2025, but margins improved and a SEK 1.75 dividend is proposed.DEDI
Q4 20256 Feb 2026 - Sharp decline in sales and profit amid tough healthcare staffing markets, with ongoing cost controls.DEDI
Q4 202410 Dec 2025 - Margins improved despite lower sales, with strategic moves supporting future growth.DEDI
Q3 202523 Oct 2025 - Sales and earnings fell significantly, but cost savings and diversification efforts are progressing.DEDI
Q2 202511 Jul 2025 - Q3 2024 saw double-digit sales and profit declines, but cost savings are set to boost Q4.DEDI
Q3 202413 Jun 2025 - Sales and earnings declined in Q2 2024, but cost savings and new contracts aim to stabilize results.DEDI
Q2 202413 Jun 2025 - Q1 2025 saw lower sales and profit, but Dedicare gained market share and stayed financially strong.DEDI
Q1 20255 Jun 2025